THU613 Multiple Endocrine Neoplasia Type 5 Associated With Germline Max Mutations—New Insights Into This Proposed Entity

Disclosure: N. Charoenngam: None. P. Likasitwatanakul: None. C. Kansuttiviwat: None. B. Ponvilawan: None. A. Jaroenlapnopparat: None. M. Tanariyakul: None. M. Mannstadt: None. Heterozygous germline loss-of-function mutations in the MAX gene, encoding the tumor suppressor MYC-associated factor X, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Charoenngam, Nipith, Likasitwatanakul, Pornlada, Kansuttiviwat, Chalermkiat, Ponvilawan, Ben, Jaroenlapnopparat, Aunchalee, Tanariyakul, Manasawee, Mannstadt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adrenal (Excluding Mineralocorticoids)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555935/
http://dx.doi.org/10.1210/jendso/bvad114.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555935/
http://dx.doi.org/10.1210/jendso/bvad114.143

Ejemplares similares